1. The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment
   Jiamin Zhou et al, 2014, BioMed Research International CrossRef
2. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways
   QI LEI et al, 2014, International Journal of Molecular Medicine CrossRef
3. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells
   JIEBING TANG et al, 2016, Oncology Reports CrossRef
4. Aspirin Action in Endothelial Cells: Different Patterns of Response Between Chemokine CX3CL1/CX3CR1 and TNF-α/TNFR1 Signaling Pathways
   Dariusz Szukiewicz et al, 2015, Cardiovascular Drugs and Therapy CrossRef
5. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells
   Santosh Kumar Singh et al, 2019, Journal of Ovarian Research CrossRef
6. Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?
   Charlie D. Zhou et al, 2022, Cancer Prevention Research CrossRef
7. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
   Xinjie Lu, 2022, Current Medicinal Chemistry CrossRef
8. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination
   Marco Erreni et al, 2016, The Journal of Immunology CrossRef
9. Crocin Upregulates CX3CR1 Expression by Suppressing NF-κB/YY1 Signaling and Inhibiting Lipopolysaccharide-Induced Microglial Activation
   Bochang Lv et al, 2016, Neurochemical Research CrossRef
10. Roles of NF-κB activation in benign prostatic hyperplasia and association between NF-κB and HIF-1α
    Young San Ko et al, 2022, Pathology - Research and Practice CrossRef
11. Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs
    Reyadh R. Al-Rashidi et al, 2023, Pharmacological Research CrossRef
12. “Find-eat” strategy targeting endothelial cells via receptor functionalized apoptotic body nanovesicle
    Shutong Qian et al, 2023, Science Bulletin CrossRef
13. Fatty Acids and Calcium Regulation in Prostate Cancer
    Ivan Maly et al, 2018, Nutrients CrossRef
14. CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling
    Dariusz Szukiewicz et al, 2014, Inflammation Research CrossRef
15. Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease
    Arnold M. Salazar et al, 2021, Neurobiology of Aging CrossRef
16. Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET
    Ido D. Weiss et al, 2017, Oncotarget CrossRef
17. Fractalkine/CX3CL1 in Neoplastic Processes
    Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
18. AKT, a Key Transmitter of HIF-1α and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells
    You-Kyung Lee et al, 2022, Biomedicines CrossRef
19. Functions of chemokines in the perineural invasion of tumors (Review)
    Mei Zhang et al, 2018, International Journal of Oncology CrossRef
20. Aqueous extract of Psoralea corylifolia L. inhibits lipopolysaccharide-induced endothelial-mesenchymal transition via downregulation of the NF-κB-SNAIL signaling pathway
    BOM JUNG et al, 2015, Oncology Reports CrossRef
21. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis
    Mohd Mughees et al, 2022, Seminars in Cancer Biology CrossRef
22. Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition
    JIEBING TANG et al, 2015, Molecular Medicine Reports CrossRef